JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Value ETF
IVE
|
+$2.05B |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$1.92B |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.13B |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$1.1B |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.24B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.12B |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$989M |
| 4 |
Microsoft
MSFT
|
+$973M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$931M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.54% |
| 2 | Technology | 14.97% |
| 3 | Healthcare | 10.91% |
| 4 | Financials | 10.87% |
| 5 | Consumer Discretionary | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
GOOS
2801
CALL
Canada Goose Holdings
GOOS
$747M
| $2.11M | ﹤0.01% |
+106,000
| New | +$2.97M |
2020 Q1
0 quarters
|
|
2802
Strategy Shares Newfound/ReSolve Robust Momentum ETF
ROMO
$26.7M
| $2.11M | ﹤0.01% |
+100,000
| New | +$2.49M |
2020 Q1
0 quarters
|
|
2803
Farmers National Banc Corp
FMNB
$902M
| $2.1M | ﹤0.01% |
180,524
+101,615
| +129% | +$1.5M |
2015 Q4
17 quarters
|
|
|
TARO
2804
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $2.1M | ﹤0.01% |
34,298
-14,288
| -29% | -$1.06M |
2015 Q4
17 quarters
|
|
2805
Hycroft Mining Holding Corp
HYMC
$1.78B
| $2.1M | ﹤0.01% |
+20,240
| New | +$2.08M |
2020 Q1
0 quarters
|
|
|
ADVM
2806
DELISTED
Adverum Biotechnologies
ADVM
| $2.09M | ﹤0.01% |
21,356
-51,958
| -71% | -$6.06M |
2014 Q3
22 quarters
|
|
2807
Ingevity
NGVT
$2.5B
| $2.09M | ﹤0.01% |
59,296
-102,325
| -63% | -$5.98M |
2016 Q2
15 quarters
|
|
|
ARD
2808
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
| $2.08M | ﹤0.01% |
175,807
-30,270
| -15% | -$531K |
2017 Q2
11 quarters
|
|
2809
IPG Photonics
IPGP
$3.56B
| $2.08M | ﹤0.01% |
18,904
+28
| +0.1% | +$3.66K |
2015 Q4
17 quarters
|
|
|
GPP
2810
DELISTED
Green Plains Partners LP
GPP
| $2.08M | ﹤0.01% |
313,305
+6,622
| +2% | +$80.6K |
2018 Q1
8 quarters
|
|
|
BSCM
2811
DELISTED
Invesco BulletShares 2022 Corporate Bond ETF
BSCM
| $2.07M | ﹤0.01% |
97,740
+1,319
| +1% | +$28.1K |
2018 Q4
5 quarters
|
|
2812
Hurco Companies Inc
HURC
$144M
| $2.06M | ﹤0.01% |
70,918
-82,581
| -54% | -$2.47M |
2013 Q2
27 quarters
|
|
2813
CALL
Marathon Petroleum
MPC
$121B
| $2.06M | ﹤0.01% |
87,300
-144,500
| -62% | -$6.66M |
2017 Q3
10 quarters
|
|
|
APLS
2814
DELISTED
Apellis Pharmaceuticals
APLS
| $2.06M | ﹤0.01% |
76,835
-350,211
| -82% | -$12.4M |
2017 Q4
9 quarters
|
|
2815
SI-BONE Inc
SIBN
$877M
| $2.04M | ﹤0.01% |
170,968
+165,665
| +3,124% | +$3.04M |
2018 Q4
5 quarters
|
|
2816
PUT
Quest Diagnostics
DGX
$25.2B
| $2.04M | ﹤0.01% |
+25,400
| New | +$2.63M |
2020 Q1
0 quarters
|
|
2817
Ovintiv
OVV
$17B
| $2.04M | ﹤0.01% |
755,658
-2,161,370
| -74% | -$28.4M |
2013 Q2
27 quarters
|
|
2818
CALL
Cummins
CMI
$73.7B
| $2.03M | ﹤0.01% |
15,000
| – | – |
2019 Q2
3 quarters
|
|
|
2819
PUT
Cummins
CMI
$73.7B
| $2.03M | ﹤0.01% |
15,000
| – | – |
2019 Q2
3 quarters
|
|
|
SOLN
2820
DELISTED
The Southern Company
SOLN
| $2.03M | ﹤0.01% |
45,700
-7,412
| -14% | -$388K |
2019 Q3
2 quarters
|
|
2821
James River Group Holdings
JRVR
$161M
| $2.03M | ﹤0.01% |
55,935
+26,473
| +90% | +$1.07M |
2015 Q4
17 quarters
|
|
2822
CALL
Realty Income
O
$51.3B
| $2.02M | ﹤0.01% |
41,796
| – | – |
2019 Q1
4 quarters
|
|
|
2823
PUT
Realty Income
O
$51.3B
| $2.02M | ﹤0.01% |
41,796
-273,480
| -87% | -$19M |
2019 Q1
4 quarters
|
|
2824
Krystal Biotech
KRYS
$9.68B
| $2.02M | ﹤0.01% |
46,645
+26,892
| +136% | +$1.41M |
2018 Q2
7 quarters
|
|
|
LOGC
2825
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
| $2.01M | ﹤0.01% |
407,921
+393,304
| +2,691% | +$3.06M |
2018 Q4
5 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2020 Portfolio in Review
As of Q1 2020, JP Morgan Chase held 6,012 positions worth $426B, down 21% from $536B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase deployed $14B of net new capital in Q1 2020, opening 362 new positions and adding to 2,382 existing holdings. Its largest new stake was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was JPMorgan BetaBuilders Japan ETF, an estimated $1.24B trimmed.
- JP Morgan Chase's largest Q1 2020 buy was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
- JP Morgan Chase added most to iShares S&P 500 Value ETF in Q1 2020, an estimated $2.05B increase.
- JP Morgan Chase's biggest Q1 2020 reduction was JPMorgan BetaBuilders Japan ETF, cutting an estimated $1.24B.
- JP Morgan Chase fully exited Liberty Property Trust in Q1 2020, selling an estimated $264M.
- JP Morgan Chase's ten largest holdings make up 18% of its $426B portfolio in Q1 2020.
- JP Morgan Chase opened 362 new positions and closed 692 in Q1 2020.
- JP Morgan Chase's portfolio value fell 21% quarter-over-quarter to $426B.
Based on JP Morgan Chase's 13F filing for Q1 2020, filed 12 May 2020.